Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07190794 · ClinicalTrials.gov registry record
RESCUE: Discontinuation of GLP-1
A clinical trial of Obesity, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 150
- Enrollment target
- 3
- Study locations
NCT07190794 is a study of Obesity that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 150 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT07190794, a study of Obesity, is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is designed to compare weight loss outcomes and safety of ESG versus lifestyle modification in patients with obesity who discontinued GLP-1 therapy due to intolerance or suboptimal weight loss.
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle Modification
- DEVICE OverStitch™ or OverStitch NXT™
Study Locations (3)
Florida
- Bariendo - Miami
Massachusetts
- Brigham & Women's Hospital - Boston
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-12-17 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07190794
The ClinicalTrials.gov registry entry for NCT07190794 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Modification is the first listed.
NCT07190794 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, West Virginia.
Frequently Asked Questions
What is clinical trial NCT07190794 about?
NCT07190794 is a clinical study titled "RESCUE: Discontinuation of GLP-1". This study is designed to compare weight loss outcomes and safety of ESG versus lifestyle modification in patients with obesity who discontinued GLP-1 therapy due to intolerance or suboptimal weight loss.
What is the current status of trial NCT07190794?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-12-17. Estimated completion is 2026-06.
What conditions does trial NCT07190794 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT07190794?
The interventions under investigation include: Lifestyle Modification (BEHAVIORAL), OverStitch™ or OverStitch NXT™ (DEVICE).
Who is sponsoring clinical trial NCT07190794?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07190794 being conducted?
This trial has 3 study locations across Florida, Massachusetts, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.